|
1
|
UNAIDS: Global HIV & AIDS statistics -
2019 fact sheet. 2020.
|
|
2
|
World Health Organisation: Latest HIV
estimates and updates on HIV policies uptake. In: Global HIV,
Hepatitis and STI Programmes. 2020.
|
|
3
|
Zeng JY, Li X, Yuan HX, Ma ML, Li DD, Ma J
and Liao S: Screening ssDNA aptamers against HIV P24 antigen using
agarose beads as carriers. Bio Web Conf. 8(10)2017.
|
|
4
|
Freed EO: HIV-1 gag proteins: Diverse
functions in the virus life cycle. Virology. 251:1–15.
1998.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wyatt R, Kwong PD, Desjardins E, Sweet RW,
Robinson J, Hendrickson WA and Sodroski JG: The antigenic structure
of the HIV gp120 envelope glycoprotein. Nature. 393:705–711.
1998.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Chan DC and Kim PS: HIV entry and its
inhibition. Cell. 93:681–684. 1998.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Guo KT, Ziemer G, Paul A and Wendel HP:
CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int J
Mol Sci. 9:668–678. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen A and Yang S: Replacing antibodies
with aptamers in lateral flow immunoassay. Biosens Bioelectron.
71:230–242. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Toh SY, Citartan M, Gopinath SC and Tang
TH: Aptamers as a replacement for antibodies in enzyme-linked
immunosorbent assay. Biosens Bioelectron. 64:392–403.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
London GM, Mayosi BM and Khati M:
Isolation and characterization of 2'-F-RNA aptamers against whole
HIV-1 subtype C envelope pseudovirus. Biochem Biophys Res Commun.
456:428–433. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mufhandu HT, Gray ES, Madiga MC, Tumba N,
Alexandre KB, Khoza T, Wibmer CK, Moore PL, Morris L and Khati M:
UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits
entry of human immunodeficiency virus type 1 subtype C. J Virol.
86:4989–4999. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tuerk C and Gold L: Systematic evolution
of ligands by exponential enrichment: RNA ligands to bacteriophage
T4 DNA polymerase. Science. 249:505–510. 1990.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Walker LM, Phogat SK, Chan-Hui PY, Wagner
D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, et al:
Protocol G Principal Investigators: Broad and potent neutralizing
antibodies from an African donor reveal a new HIV-1 vaccine target.
Science. 326:285–289. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Glökler J, Schütze T and Konthur Z:
Automation in the high-throughput selection of random combinatorial
libraries - different approaches for select applications.
Molecules. 15:2478–2490. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stoltenburg R, Reinemann C and Strehlitz
B: SELEX - a (r)evolutionary method to generate high-affinity
nucleic acid ligands. Biomol Eng. 24:381–403. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rohloff JC, Gelinas AD, Jarvis TC, Ochsner
UA, Schneider DJ, Gold L and Janjic N: Nucleic acid ligands with
protein-like side chains: Modified aptamers and their use as
diagnostic and therapeutic agents. Mol Ther Nucleic Acids.
3(e201)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Song KM, Lee S and Ban C: Aptamers and
their biological applications. Sensors (Basel). 12:612–631.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ulrich H, Martins AH and Pesquero JB: RNA
and DNA aptamers in cytomics analysis. Cytometry A. 59:220–231.
2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Osborne SE, Matsumura I and Ellington AD:
Aptamers as therapeutic and diagnostic reagents: Problems and
prospects. Curr Opin Chem Biol. 1:5–9. 1997.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Osborne SE, Volker J, Stevens SY,
Breslauer KJ and Glick GD: Design, synthesis, and analysis of
disulfide cross-linked DNA duplexes. J Am Chem Soc.
118:11993–12003. 1996.
|
|
21
|
Zhang H, Wang Z, Li XF and Le XC:
Ultrasensitive detection of proteins by amplification of affinity
aptamers. Angew Chem Int Ed. 45:1576–1580. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pavski V and Le XC: Detection of human
immunodeficiency virus type 1 reverse transcriptase using aptamers
as probes in affinity capillary electrophoresis. Anal Chem.
73:6070–6076. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cao Y, Dong H, Yang Z, Zhong X, Chen Y,
Dai W and Zhang X: Aptamer-conjugated graphene quantum
dots/porphyrin derivative theranostic agent for intracellular
cancer-related microrna detection and fluorescence-guided
photothermal/photodynamic synergetic therapy. ACS Appl Mater
Interfaces. 9:159–166. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Moutsiopoulou A, Broyles D, Dikici E,
Daunert S and Deo SK: Molecular aptamer beacons and their
applications in sensing, imaging, and diagnostics. Small.
15(e1902248)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cohen C, Forzan M, Sproat B, Pantophlet R,
McGowan I, Burton D and James W: An aptamer that neutralizes R5
strains of HIV-1 binds to core residues of gp120 in the CCR5
binding site. Virology. 381:46–54. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Alexandre KB, Gray ES, Mufhandu H, McMahon
JB, Chakauya E, O'Keefe BR, Chikwamba R and Morris L: The lectins
griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to
the DC-SIGN receptor and transfer to CD4(+) cells. Virology.
423:175–186. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Koniev O and Wagner A: Developments and
recent advancements in the field of endogenous amino acid selective
bond forming reactions for bioconjugation. Chem Soc Rev.
44:5495–5551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shapiro R, Ellis S, Hingerty BE and Broyde
S: Effect of ring size on conformations of aromatic amine-DNA
adducts: The aniline-C8 guanine adduct resides in the B-DNA major
groove. Chem Res Toxicol. 11:335–341. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Castronovo M, Radovic S, Grunwald C,
Casalis L, Morgante M and Scoles G: Control of steric hindrance on
restriction enzyme reactions with surface-bound DNA nanostructures.
Nano Lett. 8:4140–4145. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xu F, Pellino AM and Knoll W:
Electrostatic repulsion and steric hindrance effects of surface
probe density on deoxyribonucleic acid (DNA)/peptide nucleic acid
(PNA) hybridisation. Thin Solid Films. 516:8634–8639. 2008.
|
|
31
|
Yue Y, Li G, Yang Y, Zhang W, Pan H, Chen
R, Shi F and Jin Y: Regulation of Dscam exon 17 alternative
splicing by steric hindrance in combination with RNA secondary
structures. RNA Biol. 10:1822–1833. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Alexandre KB, Gray ES, Lambson BE, Moore
PL, Choge IA, Mlisana K, Karim SS, McMahon J, O'Keefe B, Chikwamba
R, et al: Mannose-rich glycosylation patterns on HIV-1 subtype C
gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and
Scytovirin. Virology. 402:187–196. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Alexandre KB, Moore PL, Nonyane M, Gray
ES, Ranchobe N, Chakauya E, McMahon JB, O'Keefe BR, Chikwamba R and
Morris L: Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N
and SVN. Virology. 446:66–76. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhou J, Swiderski P, Li H, Zhang J, Neff
CP, Akkina R and Rossi JJ: Selection, characterization and
application of new RNA HIV gp 120 aptamers for facile delivery of
Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res.
37:3094–3109. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gray ES, Madiga MC, Hermanus T, Moore PL,
Wibmer CK, Tumba NL, Werner L, Mlisana K, Sibeko S, Williamson C,
et al: CAPRISA002 Study Team: The neutralization breadth of HIV-1
develops incrementally over four years and is associated with
CD4+ T cell decline and high viral load during acute
infection. J Virol. 85:4828–4840. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lekkerkerker AN, Ludwig IS, van Vliet SJ,
van Kooyk Y and Geijtenbeek TB: Potency of HIV-1 envelope
glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN
with HIV-1 gp120. Virology. 329:465–476. 2004.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kojima T, Takei Y, Ohtsuka M, Kawarasaki
Y, Yamane T and Nakano H: PCR amplification from single DNA
molecules on magnetic beads in emulsion: Application for
high-throughput screening of transcription factor targets. Nucleic
Acids Res. 33(e150)2005.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Guttman M, Padte NN, Huang Y, Yu J,
Rocklin GJ, Weitzner BD, Scian M, Ho DD and Lee KK: The influence
of proline isomerization on potency and stability of anti-HIV
antibody 10E8. Sci Rep. 10(14313)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Huang J, Kang BH, Pancera M, Lee JH, Tong
T, Feng Y, Imamichi H, Georgiev IS, Chuang GY, Druz A, et al: Broad
and potent HIV-1 neutralization by a human antibody that binds the
gp41-gp120 interface. Nature. 515:138–142. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rigg RJ, Dando JS, Escaich S, Plavec I and
Böhnlein E: Detection of intracellular HIV-1 Rev protein by flow
cytometry. J Immunol Methods. 188:187–195. 1995.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Grace Mothepane London: Isolation,
Characterization and efficacy studies of 2'-F-RNA aptamers against
HIV-1 subtype C enveloped pseudovirus. p292, 2013.
|
|
42
|
Wang YK, Zou Q, Sun JH, Wang HA, Sun X,
Chen ZF and Yan YX: Screening of single-stranded DNA (ssDNA)
aptamers against a zearalenone monoclonal antibody and development
of a ssDNA-based enzyme-linked oligonucleotide assay for
determination of zearalenone in corn. J Agric Food Chem.
63:136–141. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Torrini F, Palladino P, Brittoli A,
Baldoneschi V, Minunni M and Scarano S: Characterization of
troponin T binding aptamers for an innovative enzyme-linked
oligonucleotide assay (ELONA). Anal Bioanal Chem. 411:7709–7716.
2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xiang D, Zheng C, Zhou SF, Qiao S, Tran
PH, Pu C, Li Y, Kong L, Kouzani AZ, Lin J, et al: Superior
performance of aptamer in tumor penetration over antibody:
Implication of aptamer-based theranostics in solid tumors.
Theranostics. 5:1083–1097. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Margolis DM, Koup RA and Ferrari G: HIV
antibodies for treatment of HIV infection. Immunol Rev.
275:313–323. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
McSharry JJ: Analysis of virus-infected
cells by flow cytometry. Methods. 21:249–257. 2000.PubMed/NCBI View Article : Google Scholar
|
|
47
|
McSharry JJ, Costantino R, Robbiano E,
Echols R, Stevens R and Lehman JM: Detection and quantitation of
human immunodeficiency virus-infected peripheral blood mononuclear
cells by flow cytometry. J Clin Microbiol. 28:724–733.
1990.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Rong Y, Chen H, Zhou XF, Yin CQ, Wang BC,
Peng CW, Liu SP and Wang FB: Identification of an aptamer through
whole cell-SELEX for targeting high metastatic liver cancers.
Oncotarget. 7:8282–8294. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Singh AA, Pooe O, Kwezi L, Lotter-Stark T,
Stoychev SH, Alexandra K, Gerber I, Bhiman JN, Vorster J, Pauly M,
et al: Plant-based production of highly potent anti-HIV antibodies
with engineered posttranslational modifications. Sci Rep.
10(6201)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ying G, Zhu F, Yi Y, Chen J, Mei J, Zhang
Y and Chen S: Selecting DNA aptamers for endotoxin separation.
Biotechnol Lett. 37:1601–1605. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Bhatt N, Huang PJ, Dave N and Liu J:
Dissociation and degradation of thiol-modified DNA on gold
nanoparticles in aqueous and organic solvents. Langmuir.
27:6132–6137. 2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zheng Q, Jockusch S, Zhou Z and Blanchard
SC: The contribution of reactive oxygen species to the
photobleaching of organic fluorophores. Photochem Photobiol.
90:448–454. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Jayasena SD: Aptamers: An emerging class
of molecules that rival antibodies in diagnostics. Clin Chem.
45:1628–1650. 1999.PubMed/NCBI
|
